Avant's Ty800 meets typhoid endpoints

Avant (NASDAQ:AVAND) said Ty800 met the primary

Read the full 77 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE